Business Wire

DNA Script Raises $165M in Oversubscribed Series C Financing to Accelerate Commercialization of Enzymatic DNA Printing Platform

SOUTH SAN FRANCISCO, Calif. & PARIS--(BUSINESS WIRE)--DNA Script, a pioneer in Enzymatic DNA Synthesis (EDS) and DNA printing on demand, today announced it has raised $165 million in a Series C ...
Business Wire

DNA Script Presents New Data Demonstrating the Feasibility of the Company’s Enzymatic Synthesis Technology

SOUTH SAN FRANCISCO--(BUSINESS WIRE)--DNA Script today announced the presentation of new data in support of the company’s innovative enzymatic DNA synthesis (EDS) technology. The data demonstrate the ...